ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 17 filers reported holding ZEALAND PHARMA A S in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 500,000 | $17,500,000 | 0.14% |
| AWM Investment Company, Inc. | 19,981 | $699,000 | 0.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 5,653 | $187,000 | 0.06% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,103,980 | $38,640,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 10,000 | $350,000 | 0.00% |
| Winslow, Evans & Crocker, Inc. | 235 | $8,000 | 0.00% |
| Rockefeller Capital Management L.P. | 4,994 | $175,000 | 0.00% |
| JANE STREET GROUP, LLC | 36,331 | $1,272,000 | 0.00% |
| Renaissance Technologies | 26,000 | $910,000 | 0.00% |
| US BANCORP \DE\ | 260 | $9,000 | 0.00% |